52 Participants Needed

HEPA Filters for Cardiometabolic Health

ZC
JZ
Overseen ByJunfeng Zhang, PhD
Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: University of Southern California
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of HEPA filters as a treatment for cardiometabolic health?

Research shows that reducing exposure to fine particulate matter (tiny particles in the air) with air cleaners can improve heart health. A study called the Cardiac Rehabilitation Air Filter Trial (CRAFT) tested air cleaners in heart patients and found potential health benefits.12345

How does the HEPA filter treatment for cardiometabolic health differ from other treatments?

The HEPA filter treatment is unique because it focuses on reducing exposure to fine particulate matter (tiny particles in the air) by filtering indoor air, which may help improve cardiovascular health. Unlike traditional treatments that might involve medication or lifestyle changes, this approach uses air filtration to potentially lower the risk of heart-related issues by improving air quality.46789

What is the purpose of this trial?

The goal of this randomized, double-blind, crossover trial is to test the hypothesis that a longer-term indoor HEPA filtration intervention can improve cardiometabolic profiles by reducing indoor PM2.5 exposures in at-risk individuals.

Research Team

ZC

Zhanghua Chen, PhD

Principal Investigator

University of Southern California

JZ

Junfeng Zhang, PhD

Principal Investigator

Duke University

Eligibility Criteria

This trial is for people aged 65-84 living in Los Angeles County who are overweight (BMI ≥ 25 kg/m2 historically), non-smokers for at least a year, have Wi-Fi at home, and speak English or Spanish. It's not for those with active cancer treatment, plans to move soon, certain health conditions, homes unsuitable for air purifiers or already equipped with HEPA filters.

Inclusion Criteria

I am between 65 and 84 years old.
Nonsmoker for at least 1 year
History of BMI ≥ 25 kg/m2 in the past based on EMR information
See 1 more

Exclusion Criteria

Have high blood glucose from finger stick test (> 200 mg/dL)
I am currently undergoing treatment for cancer.
The residential house has already had HEPA filters
See 5 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

HEPA Intervention

Participants receive HEPA filters to reduce PM2.5 levels at their residence for 6 months

6 months
Multiple home visits for setup and data collection

Wash-out

A 6-month wash-out period where no intervention is applied

6 months

Sham Intervention

Participants receive sham filters without the capacity to reduce PM2.5 levels for 6 months

6 months
Multiple home visits for setup and data collection

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • HEPA filter
  • Sham filter
Trial Overview The study tests if using HEPA filters in the home can improve heart and metabolic health by reducing fine particle pollution indoors. Participants will be randomly assigned to use either a real HEPA filter or a fake one without knowing which they have.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: HEPA first and shamExperimental Treatment2 Interventions
This group of participants will be assigned an intervention of HEPA filters with the capacity to reduce PM2.5 levels at their residence for 6 months. After 6-month wash-out period, will be assigned to sham filters for 6 months.
Group II: Sham first and HEPAPlacebo Group2 Interventions
This group of participants will be assigned an intervention of sham filters without the capacity to reduce PM2.5 levels at their residence for 6 months. After 6-month wash-out period, will be assigned to HEPA filters for 6 months.

HEPA filter is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as HEPA filter for:
  • Air purification for reducing PM2.5 exposures
  • Improvement of cardiometabolic health
🇪🇺
Approved in European Union as HEPA filter for:
  • Air purification for reducing PM2.5 exposures
  • Improvement of cardiometabolic health

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Southern California

Lead Sponsor

Trials
956
Recruited
1,609,000+

Duke University

Collaborator

Trials
2,495
Recruited
5,912,000+

Findings from Research

In a pilot study involving 20 elderly cardiac patients, the use of active portable air cleaners (PACs) significantly reduced personal PM2.5 exposure by 43.8% compared to sham devices, indicating their effectiveness in improving air quality for at-risk individuals.
The findings suggest that using inexpensive in-home PACs could lead to substantial long-term health benefits for cardiac patients by potentially reducing the risk of cardiovascular events, even in areas with generally good air quality.
Reduced Fine Particulate Matter Air Pollution Exposures Using In-Home Portable Air Cleaners: PILOT RESULTS OF THE CARDIAC REHABILITATION AIR FILTER TRIAL (CRAFT).Bard, RL., Rubenfire, M., Fink, S., et al.[2021]
A study of over 155,000 ischemic stroke admissions among Medicare recipients found that short-term increases in PM10 particulate matter were associated with a 1.03% increase in admissions on the same day, indicating a potential risk factor for ischemic stroke.
In contrast, no significant association was found between particulate matter and hemorrhagic stroke admissions, suggesting that air pollution may specifically impact the risk of ischemic strokes rather than hemorrhagic ones.
Air pollution and hospital admissions for ischemic and hemorrhagic stroke among medicare beneficiaries.Wellenius, GA., Schwartz, J., Mittleman, MA.[2016]
Fine particulate air pollution (PM2.5) is recognized as a significant risk factor for heart and lung diseases, highlighting the urgent need for effective interventions.
Personal-level strategies to reduce PM2.5 exposure have shown potential health benefits, and further randomized clinical trials are necessary to assess their feasibility and efficacy, especially in vulnerable populations.
Cardiopulmonary Impact of Particulate Air Pollution in High-Risk Populations: JACC State-of-the-Art Review.Newman, JD., Bhatt, DL., Rajagopalan, S., et al.[2023]

References

Reduced Fine Particulate Matter Air Pollution Exposures Using In-Home Portable Air Cleaners: PILOT RESULTS OF THE CARDIAC REHABILITATION AIR FILTER TRIAL (CRAFT). [2021]
Air pollution and hospital admissions for ischemic and hemorrhagic stroke among medicare beneficiaries. [2016]
Cardiopulmonary Impact of Particulate Air Pollution in High-Risk Populations: JACC State-of-the-Art Review. [2023]
Mitigation of Aerosols Generated During Exercise Testing With a Portable High-Efficiency Particulate Air Filter With Fume Hood. [2021]
Effects of reducing exposure to air pollution on submaximal cardiopulmonary test in patients with heart failure: Analysis of the randomized, double-blind and controlled FILTER-HF trial. [2022]
Reduction of personal PM2.5 exposure via indoor air filtration systems in Detroit: an intervention study. [2021]
Assessment of the capacity of vehicle cabin air inlet filters to reduce diesel exhaust-induced symptoms in human volunteers. [2022]
High-performance inertial impaction filters for particulate matter removal. [2023]
Health benefits of particle filtration. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security